(Press-News.org) NEW YORK, Oct. 3, 2023 — Mandë Holford, a professor in the Chemistry and Biochemistry departments at Hunter College and The City University of New York Graduate Center (CUNY Graduate Center), has won a National Institutes of Health Common Fund Pioneer Award for her trailblazing research exploring the therapeutic opportunities and properties of venoms from cephalopods and other marine mollusks. Holford received one of eight Pioneer Awards granted in 2023, which will total more than $47.7 million over five years.
This is the first time a CUNY faculty member has received the NIH Director’s Pioneer Award. It will provide $5.5 million over five years to conduct research and to fund postdoctoral, graduate, and undergraduate student researchers in Holford’s laboratories.
“The NIH Pioneer Award provides resources that will allow my team to go where science takes us and ask really bold questions,” Holford said. “Studying the evolutionary genetics of venom development in cephalopods such as squids, cuttle fish, and octopuses opens the door to discoveries that can have transformative effects on fundamental science and disease research by enabling drug discoveries that broadly bolster the NIH’s mission of enhancing human health.”
Established in 2004, the Pioneer Award enables investigators to pursue high-risk, high-reward research leading to breakthroughs in biomedical or behavioral science. Holford and her team will use the funds to pursue a new direction for venom research that could benefit developmental cellular and molecular biology, as well as drug discovery and development. Their study of cephalopods will provide the tools and models for tackling biological and translational questions about venoms in living organisms.
Venom production is a complex trait that has evolved in more than 200,000 creatures representing some 15% to 30% of animals. Thus, studying its evolution has broad applications for science, including understanding the development of similar tissues, the origins of novel genes, and the molecular mechanisms behind the regulation and expression of bioactive compounds.
But the most exciting applications for venoms may be in medicine. Venom-derived therapeutics now treat a number of conditions, including diabetes, heart disease, and pain, but the full potential of venom for medicine and biology remains untapped.
“We have just scratched the surface of venom research,” said Holford, whose group was the first to identify the utility of terebrid mollusk venom peptides in mitigating pain and suppressing tumors. “We need model systems to revolutionize the study of venom gland biology so that we can radically transform how we generate, manipulate, and use venom arsenals.”
About Hunter College
Located in the heart of Manhattan, Hunter is the largest college in the City University of New York (CUNY) system. Founded in 1870, it is also one of the oldest public colleges in the country and famous for a student body that is as diverse as the city itself. Most Hunter students are the first in their families to attend college and many go on to top professional and graduate programs, winning Rhodes and Fulbright scholarships, Mellon fellowships, National Institutes of Health grants, and other competitive honors. More than 23,000 students attend Hunter, pursuing undergraduate and graduate degrees in more than 170 areas of study. The 1,700 full- and part-time members of Hunter’s faculty are unparalleled. They receive prestigious national grants, contribute to the world's leading academic journals, and play major roles in cutting-edge research. They are fighting cancer, formulating public policy, expanding our culture, enhancing technology, and more.
About The City University of New York Graduate Center
The CUNY Graduate Center is a leader in public graduate education devoted to enhancing the public good through pioneering research, serious learning, and reasoned debate. The Graduate Center offers ambitious students nearly 50 doctoral and master’s programs of the highest caliber, taught by top faculty from throughout CUNY — the nation’s largest urban public university. Through its nearly 40 centers, institutes, initiatives, and the Advanced Science Research Center, the Graduate Center influences public policy and discourse and shapes innovation. The Graduate Center’s extensive public programs make it a home for culture and conversation.
END
Marine chemical biologist Mandë Holford wins prestigious National Institutes of Health Pioneer Award for Venom Research
The first-ever City University of New York researcher selected for the award, Holford will receive $5.5 million to explore new directions for using cephalopod venoms and their evolutionary dynamics in drug discovery.
2023-10-03
ELSE PRESS RELEASES FROM THIS DATE:
Synthetic peptide could reduce vascular problems associated with COVID-ARDS
2023-10-03
AUGUSTA, Ga. (Oct. 4, 2022) – A synthetic peptide developed by researchers at the Medical College of Georgia could help reduce vascular problems associated with acute respiratory distress syndrome in COVID-19.
In severe cases, COVID-19 is associated with the syndrome, which happens when fluid builds up in the tiny, elastic air sacs in the lungs, keeping them from filling with enough air and keeping oxygen from reaching the bloodstream. “These are the people who get the sickest from ...
Cardiology compensation and production remain relatively stable year-over-year
2023-10-03
MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2023 Cardiovascular Provider Compensation and Production Survey Report that includes data from the largest number of providers since its debut. The report features a foreword from MedAxiom President and CEO Jerry Blackwell, MD, MBA, FACC, on the consistency of year-over-year data from 2021 to 2022, the importance of a robust pool of data to form the foundation of the report, and the application of data as a strategic planning tool.
2023 Report Highlights:
Compensation and production ...
Optimizing continuous-variable functions with quantum annealing
2023-10-03
Quantum annealing (QA) is a cutting-edge algorithm that leverages the unique properties of quantum computing to tackle complex combinatorial optimization problems (a class of mathematical problems dealing with discrete-variable functions). Quantum computers use the rules of quantum physics to solve such problems potentially faster than classical computers. In essence, they can explore multiple solutions to a problem simultaneously, giving them a significant speed advantage for certain tasks over classical computers. In particular, QA harnesses the phenomenon of “quantum ...
City of Hope opens first U.S. multicenter clinical trial for robotic single-port mastectomies for breast cancer patients
2023-10-03
LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States, is opening a multicenter clinical trial to evaluate the efficacy of robotic-assisted, single-incision mastectomies. The minimally invasive procedure, which preserves the nipple and leaves only a small hidden scar on the side of the body, could potentially lead to significant improvements for breast surgery.
“City of Hope is once again taking the lead in investigating innovations, treatments and therapies that are making big leaps forward for patients with cancer. We’re participating ...
Emerging drug discovery ecosystems in Virginia
2023-10-03
Oak Brook, IL – A Special Issue of SLAS Discovery, Emerging Drug Discovery Ecosystems, is new for September. Volume 28, Issue 6 features three perspectives, one original research article and one protocol that align with the Virginia Drug Discovery Consortium (VaDDC) and its efforts to enhance and promote drug discovery and development in the Commonwealth of Virginia.
Perspective
An acute respiratory distress syndrome drug development collaboration stimulated by the Virginia Drug Discovery Consortium
This ...
Socioeconomic status and power outages
2023-10-03
Communities with more socioeconomic vulnerability experience longer-duration power outages than more advantaged communities, according to a study. Research has shown that environmental disasters hit economically and socially vulnerable communities hardest. Scott Ganz and colleagues assessed the unequal impacts caused by the procedures electric utilities follow to restore power to customers after extreme-weather related outages. Using data from eight Atlantic hurricanes that made landfall between January 2017 and October 2020, which knocked out power for a total of over 15 million customers in 588 counties in the Southeast, the authors find ...
Broad Clinical Labs established to expand clinical services
2023-10-03
The Genomics Platform at the Broad Institute of MIT and Harvard has been one of the world’s leading academic genome sequencing centers since the days of the Human Genome Project. For the last decade, these services have included clinical sequencing and other molecular assays through its wholly-owned subsidiary, the Clinical Research Sequencing Platform.
Now renamed Broad Clinical Labs (BCL), the lab is poised to further accelerate the power of ’omics technologies in clinical research, screening, and diagnostics.
BCL supports large-scale projects for which results need to be generated under a clinical quality system, such as analyses for clinical trials, biobank profiling, ...
Bioengineering breakthrough increases DNA detection sensitivity by 100 times
2023-10-03
UMass Amherst researchers have pushed forward the boundaries of biomedical engineering one hundredfold with a new method for DNA detection with unprecedented sensitivity.
“DNA detection is in the center of bioengineering,” says Jinglei Ping, lead author of the paper that appeared in Proceedings of the National Academy of Sciences. Ping is an assistant professor of mechanical and industrial engineering, an adjunct assistant professor in biomedical engineering and affiliated with the Center for Personalized Health Monitoring of the Institute for Applied Life Sciences. “Everyone ...
Type 2 diabetes diagnosis at age 30 can reduce life expectancy by up to 14 years
2023-10-03
An individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years, an international team of researchers has warned.
Even people who do not develop the condition until later in life – with a diagnosis at age 50 years – could see their life expectancy fall by up to six years, an analysis of data from 19 high-income countries found.
The researchers say the findings, published in The Lancet Diabetes & Endocrinology, highlight the urgent need to ...
New $81million NIH grant will help U.S. answer urgent need for better dementia care
2023-10-03
Watching a loved one suffer the slow decline of dementia is hard enough.
But trying to find care for them that’s high-quality, safe, available and affordable is nearly as difficult, as millions of American families have found out the hard way in recent years.
That lack of options stems from a combination of workforce shortages, payment policies and a lack of consistency in dementia care delivery and regulation, according to experts from the University of Michigan and the University of California, San Francisco and their colleagues.
Now, fueled by new five-year funding expected to total $81 million from the NIH’s National Institute on Aging or ...
LAST 30 PRESS RELEASES:
Insulin resistance is linked to over 30 diseases – and to early death in women, study of people in the UK finds
Innovative semaglutide hydrogel could reduce diabetes shots to once a month
Weight loss could reduce the risk of severe infections in people with diabetes, UK research suggests
Long-term exposure to air pollution and a lack of green space increases the risk of hospitalization for respiratory conditions
Better cardiovascular health in early pregnancy may offset high genetic risk
Artificial intelligence method transforms gene mutation prediction in lung cancer: DeepGEM data releases at IASLC 2024 World Conference on Lung Cancer
Antibody–drug conjugate I-DXd shows clinically meaningful response in patients with extensive-stage small cell lung cancer
IASLC Global Survey on biomarker testing reveals progress and persistent barriers in lung cancer biomarker testing
Research shows pathway to developing predictive biomarkers for immune checkpoint inhibitors
Just how dangerous is Great Salt Lake dust? New research looks for clues
Maroulas appointed Associate Vice Chancellor, Director of AI Tennessee
New chickadee research finds cognitive skills impact lifespan
Cognitive behavioral therapy enhances brain circuits to relieve depression
Terasaki Institute awarded $2.3 Million grant from NIH for organ transplantation research using organs-on-a-chip technology
Atoms on the edge
Postdoc takes multipronged approach to muon detection
Mathematical proof: Five satellites needed for precise navigation
Scalable, multi-functional device lays groundwork for advanced quantum applications
Falling for financial scams? It may signal early Alzheimer’s disease
Integrating MRI and OCT for new insights into brain microstructure
Designing a normative neuroimaging library to support diagnosis of traumatic brain injury
Department of Energy announces $68 million in funding for artificial intelligence for scientific research
DOE, ORNL announce opportunity to define future of high-performance computing
Molecular simulations, supercomputing lead to energy-saving biomaterials breakthrough
Low-impact yoga and exercise found to help older women manage urinary incontinence
Genetic studies reveal new insights into cognitive impairment in schizophrenia
Researcher develops technology to provide cleaner energy and cleaner water
Expect the unexpected: nanoscale silver unveils intrinsic self-healing abilities
nTIDE September 2024 Jobs Report: Gains in employment for people with disabilities appear to level off after reducing gaps with non-disabled workers
Wiley enhances NMR Spectral Library Collection with extensive new databases
[Press-News.org] Marine chemical biologist Mandë Holford wins prestigious National Institutes of Health Pioneer Award for Venom ResearchThe first-ever City University of New York researcher selected for the award, Holford will receive $5.5 million to explore new directions for using cephalopod venoms and their evolutionary dynamics in drug discovery.